NEU neuren pharmaceuticals limited

Ann: Q2 2020 Activity Report and Cash Flow Report, page-4

  1. 420 Posts.
    lightbulb Created with Sketch. 472
    In my financial model, and using the lowest percentage of royalties from Trof for Retts at 10%, I get a risk weighted valuation of 10x current EV. This doesn't take into account anything for;

    1.Trof for Fragile X
    2. Trof for US Army
    3. Trof for Autism
    4. Trof for anything else in North America
    5. Trof for ROW (Retts/fragile X)
    6. 2591 for anything in any jurisdiction

    To me it's just a waiting game. RIsk to the upside is absolutely crazy when you think about it and compare with risk to the downside. Just my opinion, so advise that you all DYOR.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.10
Change
-0.800(5.76%)
Mkt cap ! $1.629B
Open High Low Value Volume
$13.95 $13.96 $12.88 $9.534M 725.6K

Buyers (Bids)

No. Vol. Price($)
1 266 $13.10
 

Sellers (Offers)

Price($) Vol. No.
$13.15 1619 2
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.